What we do

Hovione is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Hovione has over 60 years of experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates. With four FDA inspected sites, USA, China, Ireland and Portugal, Hovione offers branded pharmaceutical customers services for the development and compliant manufacture of innovative new drugs including highly potent compounds. For generic pharmaceutical customers the company offers niche generic API products. Hovione also offers all customers proprietary product development and licensing opportunities for drug products. Hovione is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.
Hovione is a company with a culture based on innovation, quality and delivery.

hovione statement: we do well what is difficult to give our customers what they cannot find elsewhere

Brand Cornerstones

  • Strong scientific / technical capabilities
  • Exceptional people
  • 360o Quality
  • Extensive manufacturing capacity
  • Rigorous project management
  • Focused expertise in high performance products

3 primary service lines

  • Contract manufacturing services
  • Generic API products
  • Proprietary drug product licensing

4 areas of expertise in off-patent products

  • Corticosteroids
  • LABA/LAMA (Long-Acting Beta Agonists / Long-Acting Muscarinic Antagonists)
  • Antibiotics
  • Mectins

Zero FDA warning letters since 1959

Also in About Hovione

History of Hovione

Hovione was established in Portugal in 1959 by Ivan Villax with his wife, Diane Villax, and two other Hungarian refugees: Nicholas de Horthy and Andrew Onody, thus forming the name HOVIONE.